-
February 26: The Week in Cancer News
Nonprofits provide support to young cancer patients in need of fertility preservation, and a childhood cancer survivor joins the first all-civilian mission to space.
by Bradley Jones
-
Patient Advocates Tune in for Precision Medicine Primer
Scientists and physicians discussed advances in targeted therapies and immunotherapies, as well as the lessons COVID-19 research has taught to cancer researchers.
by Kevin McLaughlin
-
Immunotherapy Options for Breast Cancer
Two immune checkpoint inhibitors are now approved for treatment of some people with advanced breast cancer, but trial results have raised some questions.
by Anna Goshua
-
January 8: The Week in Cancer News
Two extremely rare cases of cancer being passed from mother to child observed in Japan, and advice on COVID-19 vaccines for cancer patients.
by Bradley Jones
-
Colorectal Cancer Screenings at Home
Stool-based tests could increase access to colorectal cancer screening.
by Jen Tota McGivney
-
Forward Look
What’s Next? Winter 2020/2021Using deep learning to detect tumor mutations.
by Christina Bennett
-
Multiple Myeloma: Choosing Your Path
New therapies provide hope and options for people as they monitor and manage this incurable blood cancer.
by Tara Haelle
-
From the Editor-in-Chief
Intercepting Cancer by Tackling PrecancerResearch on premalignancy is needed to fully tap the potential of cancer interception.
by William G. Nelson, MD, PhD
-
Are Liquid Biopsies Ready for the Clinic?
Sophisticated blood tests offer a less invasive way to characterize cancers, guide treatment and catch recurrences sooner, but tissue biopsies remain the gold standard.
by Kendall K. Morgan
-
Forward Look
Scanning DisparitiesWhether lung cancer patients receive PET scans depends on race, according to a study.
by Ashley P. Taylor
Cancer Talk
Injection Immunotherapies Get FDA Approval
Giving immunotherapy drugs as injections, rather than intravenously, means patients can spend less time in the hospital or treatment center.
by Laura Gesualdi-Gilmore
Designing Clinical Trials for the PatientChallenges in developing and studying treatments call for new ways of thinking about cancer research.
by Eric Fitzsimmons
Treating Smoldering Multiple MyelomaA monoclonal antibody drug reduced the risk of smoldering myeloma progressing to multiple myeloma in patients at high risk for disease progression.
by Sandra Gordon
Immunotherapy Improves Survival in Bladder CancerNew research indicates that adding immunotherapy to muscle-invasive bladder cancer treatment can improve event-free and overall survival.
by Laura Gesualdi-Gilmore